ArticleNeurology and therapy2026

Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.

Norio Chihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.